Following Angelina Jolie’s announcement that she carried a genetic mutation that increased her odds of developing breast and ovarian cancer, referrals for genetic counseling and BRCA1/2 testing appeared to have increased the awareness of cancer, particularly for breast cancer (79–81). This evidence concerns the gene BRCA1 and ovarian cancer.